HE homepage

So far in 2022, 832 CEOs have left their roles––and healthcare CEOs have been among the most active role departures.

Child vaccine

“With increasing global rates of Lyme disease, providing a new option for people to help protect themselves from the disease is more important than ever,” says Annaliesa Anderson, PhD, senior vice president and head of vaccine research & development at Pfizer.

Blood Cells

The deal brings together one of the biggest pharmaceutical companies in the United States with a biopharmaceutical company specializing in blood disorders.

News of the deal comes after reports that Signify Health is exploring strategic alternatives, including a sale.

Roughly 98 million adults in the United States have delayed or skipped healthcare treatments, trimmed regular household expenses or borrowed money in the past six months in order to afford healthcare.

TAVR has attracted many more patients to seek treatment for aortic valve disease, which has also helped feed more patients into surgical programs, despite TAVR now making up 84% of aortic valve replacement procedures.

A decade ago, when TAVR was first cleared by the FDA, surgeons had concern about losing business. But unexpectedly, TAVR has helped also gain heart surgery cases. 

Around the web

Clinlab.AI will oversee every aspect of this new-look laboratory, working to integrate it with the practice's workflows in a way that boosts patient care and speeds up treatment decisions.